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Summary
Rho-family GTPases are activated by the exchange of bound GDP for GTP, a process that is catalyzed
by Dbl-family guanine nucleotide exchange factors (GEFs). The catalytic unit of Dbl-family GEFs
consists of a Dbl-homology (DH) domain followed almost invariantly by a pleckstrin-homology
(PH) domain. The majority of the catalytic interface forms between the switch regions of the GTPase
and the DH domain, but full catalytic activity often requires the associated PH domain. Although PH
domains are usually characterized as lipid binding regions, they also participate in protein-protein
interactions. For example, the DH-associated PH domain of Dbs must contact its cognate GTPases
for efficient exchange. Similarly, the N-terminal DH/PH fragment of Trio, which catalyzes exchange
on both Rac1 and RhoG, is four-fold more active in vitro than the isolated DH domain. Given
continued uncertainty regarding functional roles of DH-associated PH domains, we have undertaken
structural and functional analyses of the N-terminal DH/PH cassette of Trio. The crystal structure of
this fragment of Trio bound to nucleotide-depleted Rac1 highlights the engagement of the PH domain
with Rac1 and substitution of residues involved in this interface substantially diminishes activation
of Rac1 and RhoG. Also, these mutations significantly reduce the ability of full-length Trio to induce
neurite outgrowth dependent on RhoG activation in PC-12 cells. Overall, these studies substantiate
a general role for DH-associated PH domains in directly engaging Rho GTPases for efficient guanine
nucleotide exchange and support a parsimonious explanation for the essentially invariant linkage
between DH and PH domains.
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Introduction
Rho GTPases act as molecular switches that cycle between inactive GDP-bound states and
active GTP-bound states.1-3 Once activated, Rho GTPases bind to their effectors to elicit a
variety of downstream signaling responses, including: cytoskeletal reorganization, gene
expression, cell cycle progression, membrane trafficking, cell adhesion, and cell migration.3;
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4 Given their involvement in many critical cellular processes, it is not surprising that aberrant
regulation of Rho GTPases contributes to various diseases such as cancer,5 hypertension,6 and
mental retardation.7 It is generally appreciated that delineating the mechanisms involved in
the activation of Rho GTPases might guide treatment regimens for a variety of human diseases.
The activity of Rho GTPases is regulated mainly by three classes of proteins: 1) GTPase
activating proteins (GAPs) accelerate the hydrolysis of bound GTP; 2) guanine nucleotide
dissociation inhibitors (GDIs) sequester prenyl groups added post-translationally to Rho
GTPases and thus stabilize cytosolic, inactive forms of the GTPases; and 3) Dbl-family guanine
nucleotide exchange factors (GEFs) catalyze the exchange of bound GDP for GTP, thereby
activating the GTPases.1; 8-10
Not including splice variants, the human genome encodes 69 Dbl-family GEFs10 of varying
domain architecture, size, and GTPase specificity.1; 10 All Dbl-family members contain a
conserved Dbl-homology (DH) domain, followed almost invariably by a tandem pleckstrin-
homology (PH) domain.2; 10 The DH domain forms the majority of the interface with the
GTPase and is often sufficient to catalyze nucleotide exchange10-12 and dictate GTPase
specificity.10; 11; 13 The PH domain is necessary for regulating exchange in vivo,14-18 and
in many cases, in vitro,13; 19-22 but its exact functions remain unclear.
DH-associated PH domains, like most PH domains, are traditionally characterized as
phosphoinositide binding modules; but the ability of phosphoinositides to allosterically
regulate the exchange activities of Dbl-family GEFs is, at best, controversial.16; 18; 23-25 In
addition, in several instances, DH-associated PH domains are not necessary for recruiting GEFs
to cellular membranes where they normally operate on membrane-resident GTPases. This is
true even though PH domain mutations abrogating phosphoinositide binding diminish the
ability of Dbl-family GEFs to activate their cognate GTPases in vivo.16; 18; 26; 27 Another
possibility that finds growing support is that DH-associated PH domains facilitate exchange
through direct interactions with cognate GTPases.13; 19; 20; 26; 28 For example, structures
of Dbs DH/PH in complex with nucleotide-depleted Cdc42 or RhoA (henceforth, Dbs•Cdc42
or Dbs•RhoA, respectively) show direct contacts between the β3/β4 loop of the PH domain
and its cognate GTPases.13; 28 Mutational analysis has confirmed the catalytic importance of
this interface both in vitro and in vivo and has identified His814, Gln834, and Tyr889 of Dbs
as functionally significant for guanine nucleotide exchange.18; 28 Given the highly conserved
position of PH domains directly adjacent to DH domains, it is likely that other Dbl-family
GEFs also use their DH-associated PH domains to directly engage their cognate GTPases to
facilitate guanine nucleotide exchange. In particular, published data on the Dbl-family GEF
Trio22; 29 and the C. elegans ortholog of Trio, UNC-73,26 provide strong circumstantial
support for this hypothesis.
Trio is a large, evolutionarily conserved Dbl-family GEF that is best characterized for its role
in regulating neurite outgrowth.30-37 Unlike most Dbl-family GEFs, Trio has two DH/PH
cassettes (Figure 1(a)); the first DH/PH cassette catalyzes exchange on Rac1 and RhoG,
38-41 while the second DH/PH cassette is specific for RhoA.38; 39 Physiological functions
of the C-terminal DH/PH cassette remain relatively unclear, but the N-terminal DH/PH cassette
is critical and often sufficient for regulating neuronal development through activation of RhoG,
and possibly Rac1.31; 35; 36 Interestingly, although there is some discrepancy over the relative
rates of exchange, the isolated N-terminal DH domain of Trio does not exchange as effectively
as the corresponding DH/PH cassette in vitro.22; 29 Furthermore, deletion of the PH domain
from the N-terminal DH/PH cassette of full-length Trio reduces its ability to induce neurite
outgrowth in PC-12 cells through activation of RhoG.29 Finally, residues in the PH domain
of Dbs that are functionally significant for exchange on its cognate GTPases are conserved in
Trio (Figure 1(b)). Together, these data strongly suggest that the N-terminal DH/PH cassette
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of Trio might use its PH domain similarly to Dbs when catalyzing exchange on its cognate
GTPases Rac1 and RhoG.
Thus, to better understand the possible functional interplay between the N-terminal DH and
PH domains of Trio specifically, and between DH and PH domains in general, we determined
the crystal structure of the N-terminal DH/PH cassette of Trio in complex with nucleotide-
depleted Rac1 (henceforth, Trio•Rac1). The complex recapitulates many of the interactions
involving the PH domain previously seen in the Dbs / GTPase structures that are required for
efficient guanine nucleotide exchange by Dbs. Mutation of this interface in Trio confirms the
necessary involvement of the N-terminal PH domain of Trio in directly engaging Rac1 and
RhoG for their efficient activation in vitro and in vivo. These studies further support the general
capacity of DH-associated PH domains to be active participants in the exchange process and
suggest a coherent model of guanine nucleotide exchange catalyzed by Dbl-family proteins
that requires the direct and cooperative engagement of DH domains, as well as their associated
PH domains, by Rho GTPases for their efficient activation.
Results
Structure of Trio in complex with nucleotide-depleted Rac1
A complex between the N-terminal DH/PH cassette of Trio (residues 1226 – 1536) and residues
1-189 (C189S) of Rac1 yielded poorly diffracting crystals. Since several structures of Rho
GTPases indicate that the C-terminal polybasic tail is not typically well-structured, nor directly
involved in binding GEFs,13; 19; 28; 42 a truncated version of Rac1 lacking this region and
ending at residue 177 (Rac177) was crystallized with the N-terminal DH/PH cassette of Trio
and used for structure determination of the Trio•Rac1 complex. Previous work from this lab
has shown that full-length, unprenylated Rac1 and Rac177 exhibited identical capacity to bind
guanine nucleotides and to be activated by the DH/PH cassette of Tiam1 in vitro.12 Phases
were determined for a native data set collected at the SER-CAT beamline (ID-22, Advanced
Photon Source) using Trio DH/PH43 and Rac112 as a model for molecular replacement. The
final structure has an Rwork = 22.3% and an Rfree = 24.9% and incorporates data from 19.4Å–
2.0 Å (see Table 1 for data collection and refinement statistics).
The overall domain architecture of the Trio•Rac1 structure is similar to that seen in other
complexes of Dbl-family GEFs and their GTPases; the DH domain of Trio consists of a bundle
of six α-helices while the PH domain consists of a core seven strand β-sandwich with three
inter-strand loops and a capping C-terminal helix10; 13; 28; 42; 44-46 (Figure 2(a) and 3). The
majority of the interface between Rac1 and Trio, which buries ∼2500 Å2 of surface area, is
mediated by the DH domain. However, the complex also shows significant interactions
between Rac1 and the PH domain of Trio that occur predominantly through residues in the
β3/β4 loop and His1410 (Figure 2(a) and (b)), similar to the interactions seen between Dbs and
its cognate GTPases.13; 28
There is excellent electron density for Rac1, the DH domain, and the parts of the PH domain
that contact Rac1 (Figure 2(c) and Table 1). In contrast, electron density is poor for the
remainder of the PH domain, especially the β1/β2 and β6/β7 loops, which have not been
modeled. The unusually high average B-factor for the PH domain (Table 1) suggests that it is
inherently mobile. To illustrate the predicted motion of the PH domain, we have displayed the
thermal ellipses for each atom of the Trio•Rac1 structure (Figure 2(d)). These ellipses represent
the anisotropic B-values obtained after TLS refinement47; 48 and indicate that a portion of the
PH domain is highly mobile. This observation is consistent with several reports that indicate
many DH-associated PH domains have significant conformational mobility and are often
difficult to model when crystallized.28; 42; 44 One notable exception to this generalization is
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the structure of Trio crystallized without bound GTPase.43 However, in this case, the PH
domain is locked into place by several crystal contacts.
Interestingly, the anisotropic B-values and the corresponding thermal ellipses associated with
residues of the PH domain that mediate the interface with Rac1, including those in the β3/β4
loop, are comparable to those for atoms in the DH domain and Rac1 (Figure 2(d) and data not
shown). While the majority of the PH domain has few stabilizing interactions, the interaction
of the β3/β4 loop with Rac1 appears to restrict its motion. Furthermore, a simulated annealing
omit map generated from the final model after omitting residues in the interface between the
PH domain and Rac1 and the final 2Fo-Fc map both show clear density for residues mediating
this interface (Figure 2(c)). Thus, the interactions between the DH-associated PH domain of
Trio and Rac1 illustrated in Figure 2(b) are not modeling artifacts
Comparison of Trio•Rac1 to Dbs•Cdc42
Superimposition of the structures of Trio•Rac1 with the corresponding DH/PH portion of Trio
in isolation indicates that an ∼10° rotation of the PH domain with respect to the DH domain
(toward Rac1) occurs upon complex formation. This shift mimics a similar rearrangement
within the DH/PH portion of Dbs upon engagement of Cdc42 or RhoA13; 28 (Figure 4(a) and
(b)). Consistent with sequence conservation between Dbs and Trio, the molecular interactions
between the PH domain of Trio and Rac1 are analogous to those that mediate the interface
between the PH domain of Dbs and Cdc42 (Figure 4(c) and (d)). Specifically, the interactions
between Asp65 (Rac1), His1410 (Trio, DH domain) and Tyr1472 (Trio, PH domain) mimic
the interactions between Asp65 (Cdc42), His814 (Dbs, DH domain), and Tyr889 (Dbs, PH
domain). In addition, interactions between Asp65 (Rac1), Gln1430 (Trio, PH domain), and a
bridging water molecule are recapitulated in the Dbs•Cdc42 complex. Other similar
interactions also occur within both structures, i.e., Ser1470 within the PH domain of Trio
interacts with His103 of Rac1 while Lys885 of the PH domain of Dbs interacts with His103
of Cdc42.
Functional analysis of the interface between the PH domain of Trio and Rac1
To test the functional significance of the interactions between Rac1 and the PH domain of Trio,
mutations designed to disrupt these interactions were introduced into the DH/PH fragment used
for crystallization (Figure 5) and purified mutant proteins were assayed for exchange activity
on soluble wild-type Rac1 (residues 1-189, c189s) (Figure 5(a)). Relative to the equivalent
wild-type DH/PH fragment of Trio, mutation of either His1410 to Ala, Gln1430 to Ala, or
Tyr1472 to Phe significantly decreases exchange activity. Similar to Dbs,28 mutation of
Tyr1472 to Phe produces the largest reduction in exchange activity. Substitution of Tyr 1472
to Phe was previously assessed under similar conditions43 and the two sets of measurements
are consistent. Unsurprisingly, complementary mutations within Rac1 designed to disrupt
interaction with the PH domain of Trio reduced exchange by the wild-type fragment of Trio
(Figure 5(c)), further confirming the functional importance of engaging Rac1 through the PH
domain for catalyzed exchange. The D65A and R66A mutations introduced in Rac1 lie within
the switch region responsible for binding nucleotide. However, rates of spontaneous exchange
for these mutant forms of Rac1 were no more than 2-fold higher than wild-type Rac1 (data not
shown) and these small differences cannot account for the relatively large decrement in the
capacity of Trio to activate them. The spontaneous rate of exchange for Rac1 H103A was
essentially identical to wild-type Rac1.
In this study, Trio was crystallized in complex with nucleotide-depleted Rac1, but Trio
alsoexchanges on RhoG both in vitro29; 43 and in vivo,29; 31; 40; 41 and does so approximately
three times more efficiently in vitro.43 RhoG is 80% homologous to Rac1, 65% identical, and
the residues in nucleotide-depleted Rac1 that are buried in the interface with Trio are 100%
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identical in RhoG (data not shown). Consequently, mutants of Trio that have reduced exchange
activity on Rac1 were also tested for activity on soluble, wild-type RhoG (Figure 5(b)).
Predictably, mutations within the PH domain of Trio also reduced its exchange activity on
RhoG, with Trio Y1472F exchanging the least efficiently. These data strongly suggest that the
interface between Trio and RhoG is highly similar, if not identical, to its interface with Rac1.
Circular dichroism spectroscopy (Figure 5(d)) and gel filtration chromatography (data not
shown) confirmed that all mutant forms of Trio were properly folded and monodisperse.
Wild-type Trio robustly activates RhoG through its N-terminal DH/PH cassette to promote
neurite outgrowth in PC-12 cells.31 Furthermore, mutant forms of Trio lacking the N-terminal
PH domain exhibit a reduced capacity to both activate RhoG in vitro and induce neurite
formation in PC-12 cells.29; 31 While these studies indicate the importance of the N-terminal
PH domain of Trio for guanine nucleotide exchange of its cognate GTPases and its attendant
morphological consequences, they do not address the underlying mechanistic causes for these
results. Therefore, to test the effects of disrupting specific interactions between the N-terminal
PH domain of Trio and its cognate GTPases, the single substitutions described above were
introduced into full-length Trio (3038 amino acids) and the capacity of these substituted forms
of Trio to induce neurite outgrowth of PC-12 cells was quantified (Figure 6). Consistent with
the inability of these mutant forms of Trio to activate Rac1 and RhoG efficiently in vitro, these
singly-substituted forms of full-length Trio are also significantly compromised in their capacity
to induce neurite outgrowth in PC-12 cells. Since these substitutions do not perturb the overall
fold of the isolated DH/PH fragment of Trio, it is highly unlikely that they do so within the
context of full-length Trio.
Discussion
The work presented here describes specific interactions between the N-terminal PH domain of
Trio and Rac1 or RhoG that are essential for productive activation of these GTPases. These
interactions strikingly mimic the coordinate engagement of RhoA or Cdc42 by the DH and PH
domains of Dbs. Moreover, PH domain-mediated interactions between both Trio and Dbs and
their cognate GTPases are required for efficient guanine nucleotide exchange in vitro and in
vivo and indicate that the coordinate engagement of cognate GTPases by DH and PH domains
necessary for efficient guanine nucleotide exchange might be more wide-spread than currently
appreciated.
For example, as predicted by sequence homology (Figure 1(b)), the residues in the PH domain
of Trio that mediate its interface with Rac1 are identical to the residues in the PH domain of
Dbs that mediate its interface with Cdc42 and RhoA.28 Interestingly, these residues are
conserved in other GEFs, including: Duo, Dbl, neuroblastoma, and obscurin (Figure 1(b)); and
research has shown that Dbl also requires its DH-associated PH domain to catalyze exchange
with maximal efficiency.49 Therefore, while it is not conclusive that these GEFs also require
direct engagement of their cognate GTPases by their DH-associated PH domains for full
exchange potential, sequence conservation shared among this set of GEFs strongly suggests
this possibility.
While the residues of Dbs and Trio that mediate the interface between their PH domains and
cognate GTPase are conserved only in a subset of Dbl-family GEFs, recent data shows that
more distantly related Dbl-family GEFs also use their DH-associated PH domain to engage
their cognate GTPases, albeit through different interactions. For example, the DH domains of
both LARG and PDZ-RhoGEF exchange less efficiently on RhoA than their respective DH/
PH cassette.19; 20 Not surprisingly, a comparison of the structure of LARG DH/PH to the
structure of LARG DH/PH bound to nucleotide free RhoA (henceforth LARG•RhoA) reveals
an ∼30° rotation of the PH domain, allowing contact between the PH domain and the GTPase.
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19 This rotation is similar to that seen with both Trio and Dbs upon engaging the nucleotide-
free GTPase.44 However, instead of allowing contact between the cognate GTPases and the
β3/β4 loop of the respective PH domains, the LARG•RhoA structure and the structure of PDZ-
RhoGEF bound to RhoA both reveal contacts between RhoA and residues in the αC helix of
the PH domains19; 20 In the case of LARG•RhoA, mutational analysis has shown that these
contacts are functionally significant. The structure of LARG•RhoA and accompanying
biochemical analyses also reveal functionally significant contacts between the GTPase and the
β1 strand of the PH domain which are mediated through Arg 986 in the αN helix of the PH
domain.19 The αN helix extends from the C-terminus of the α6 helix of the DH domain,19 and
interestingly, similar contacts are seen between the GTPase and C-terminus of the α6 helix of
Trio, Dbs, and PDZ-RhoGEF.20; 28 In the cases of PDZ-RhoGEF and LARG, the in vivo
relevance of contacts between the PH domain and the GTPase has not been pursued. LARG
and PDZ-RhoGEF belong to a subset of Dbl-family GEFs that include Lfc and p114-RhoGEF;
further analysis is needed to determine if other members of this subset also require their DH-
associated PH domains for maximal guanine nucleotide exchange.
In contrast to Dbs, Trio, LARG, and PDZ-RhoGEF, crystals structures of the DH/PH cassettes
of the Dbl-family GEFs Tiam1,12 intersectin,13 and collybistin,42 in complex with their
cognate GTPases show little or no contact between their PH domains and their cognate GTPase.
While these structures might indicate that not all Dbl-family GEFs use their DH-associated PH
domain to engage cognate GTPases for effective exchange, it has been suggested that these
structures might not precisely reflect the molecular details of the exchange process in vivo.
16-18; 28 Specifically, Dbl-family GEFs operate on membrane-resident GTPases and it has
been proposed that biological membranes impose additional constraints on the conformational
flexibility of DH/PH cassettes such that specific conformers are favored that could promote
direct interactions between GTPases and DH-associated PH domains necessary for full
exchange activity.16; 18; 28 Indeed, many DH-associated PH domains have been shown to
bind various phosphoinositides with micromolar affinities,23; 50 and while these protein-lipid
interactions are not normally considered sufficient to drive subcellular re-localization,45 they
might provide points of membrane attachment that would favor specific conformers or
orientations of DH/PH cassettes that stabilize interactions between DH-associated PH domains
and GTPases necessary for full catalytic exchange. Studies of Tiam116 and Dbs18; 27 provide
substantial support for this scenario.
There is evidence that due to the conformational flexibility within the DH/PH cassettes,
structural studies provide only a partial description of the exchange process. For example, there
are four independent copies of the DH/PH cassette of Dbs in the crystal structure of this
fragment without bound GTPase.44 In each of the four molecules, the position of the PH
domain is different relative to the DH domain. Much of this conformational flexibility is lost
when Dbs engages a cognate GTPase as evidenced in the crystal structures of Dbs bound to
either RhoA13 or Cdc42.28 Similarly, the structure of collybistin in complex with Cdc42 shows
two conformers of the DH/PH cassette within the asymmetric unit that differ by an ∼35 degree
rotation of the PH domain with respect to the DH domain.42 Sos presents an extreme example.
In this case, the PH domain occludes the GTPase-binding site on the DH domain,51; 52 and
the DH/PH fragment alone is incapable of activating GTPases in vitro (S. Soisson, personal
communication). However, Sos-1 does activate Rac in vivo,14 and for this to occur, the PH
domain must undergo a dramatic rearrangement from its position relative to the DH domain
to allow binding and activation of Rac. Some evidence suggests that the E3b1/Eps8 complex
activates Sos-1 downstream of Ras and PI3K,53; 54 but the molecular details of the Sos DH/
PH rearrangement remain unclear. In the case of Trio, we show here that portions of the PH
domain that are not in direct contact with Rac1 are highly mobile in the crystal structure of the
Trio•Rac1 complex. This mobility does not manifest in the crystal structure of the DH/PH
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fragment of Trio in isolation. However, in this case, lattice contacts within the crystal clearly
limit possible motion.
The studies presented here support earlier indications that the N-terminal PH domain of Trio
is required for the activation of its cognate GTPases, and together with previous studies of Dbs,
13; 28 provide detailed mechanistic information regarding roles of DH-associated PH domains
in directly engaging GTPases for their activation in vivo. PH domains associated with DH
domains might function in a variety of contexts to support activation of GTPases. However,
an attractive and parsimonious model posits that both of the two domains must engage cognate
GTPases for their effective and regulated activation in vivo. The inherent flexibility between
DH and PH domains would be restricted under controlled cellular conditions, i.e., at
membranes and upon the binding of specific phosphoinositides to the PH domain, which would
favor productive engagement of both portions of the cassette with cognate GTPases. Under
extreme conditions, such as Sos, the PH domain would move off the surface of the DH domain
to allow access by GTPases51; 52 and this movement might also be controlled by membranes
and phosphoinositide binding to the DH-associated PH domain. Alternatively, the
conformation of the DH/PH cassette might be altered by interaction with currently unknown
protein activators. In all cases though, the DH and PH domains would act cooperatively to
integrate various cellular inputs leading to Rho GTPases activation; the PH domain would not
be a simple membrane localization device, but more properly thought of as an intrinsic




The sequences of Dbs (NP 079255), Trio (NP 009049), Duo (NP 003938), Dbl (NP
005360), Duet (NP 008995), PRex1 (NP 065871), p63RhoGEF (NP 891992), Lfc (NP
004714), neuroblastoma (NP 005263), and obscurin (NP 443075) shown in Figure 1(b) were
aligned using Clustal X.55 The NCBI accession numbers are given in parentheses.
Protein preparation for guanine nucleotide exchange assays
Human Trio DH/PH (residues 1226 – 1535) (kindly provided by Dr. Yi Zheng, Cincinnati
Children's Hospital Medical Center), was encoded as a fusion with an N-terminal His6-tag in
pET15a (Novagen), expressed in the BL21 (DE3) E. coli strain, and purified similarly to
published protocols.28; 56 Briefly, transformed cells were grown in LB media containing 0.1
mg/ml ampicillin at 37°C to an OD600 of 0.7 (mid-log phase) and induced with 1 mM isopropyl-
β-D-thiogalactopyranoside (IPTG) at 27°C for 5 hours. Harvested cells were resuspended in
50 mM NaH2PO4, pH 8, 300 mM NaCl (buffer A), and 5mM imidazole and lysed with an
Emulsi-Flex C5 (Avestin). Lysate was clarified by centrifugation at > 125,000 × g for 30
minutes prior to loading the supernatant onto a Ni2+-Sepharose affinity column (GE
Healthcare) equilibrated in buffer A containing 5 mM imidazole. The column was washed with
buffer A containing 55 mM imidazole and Trio eluted with buffer A containing 400 mM
imidazole. The protein was further purified using a 26/60 Sephacryl-200 size exclusion column
(GE Healthcare) equilibrated with 50 mM Tris, pH 8, 2 mM DTT, 2mM EDTA, 150 mM NaCl,
and 5% glycerol. Fractions containing Trio were pooled, concentrated, and stored at −80°C.
Human Rac1 (residues 1-189, C189S) was expressed from pET21a (Novagen) in the BL21
(DE3) E. coli strain. Transformed cells were grown and induced similarly to cells expressing
Trio. Harvested cells were resuspended in 10 mM MES, pH 6, 2 mM DTT, 10% glycerol, 1
mM MgCl2 (buffer B) and 10 mM NaCl prior to lysis and clarification as described above.
Supernatant was loaded onto an SP-Sepharose Fast Flow 26/10 column (GE Healthcare). Rac1
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was eluted from the column using buffer B with an increasing gradient of NaCl and further
purified using a 26/60 Sephacryl-200 size exclusion column (GE Healthcare) equilibrated with
50 mM Tris, pH 8, 2 mM DTT, 2mM MgCl2, 150 mM NaCl, and 5% glycerol. Fractions
containing Rac1 were pooled, concentrated, and stored at −80°C.
Human RhoG (residues 1-188, C188S) was expressed from the pGEX4TEV2 vector57 with
an N-terminal GST-tag in the BL21 (DE3) E. coli strain. Transformed cells were grown in LB
media containing 0.1 mg/ml ampicillin at 37°C to an OD600 of 0.7 (mid-log phase) and induced
with 1 mM IPTG at 20°C for 16 hours to 18 hours. Cells were resuspended in buffer C (150
mM NaCl, 20 mM Tris, pH 8, 2 mM DTT, 1 mM MgCl2, 10 μM GDP, and 5% glycerol) prior
to lysis and clarification as described above. Supernatant was loaded onto a GST-Sepharose
affinity column (GE Healthcare) equilibrated in buffer C; the column was washed with buffer
C, and RhoG eluted with buffer C containing 10 mM glutathione (reduced). The GST tag was
removed by cutting with TEV while dialyzing against buffer C overnight. The protein was
further dialyzed against buffer D (10 mM MES, pH 6, 2 mM DTT, 2 mM MgCl2, 10 μM GDP,
and 5% glycerol) and applied to a Source-S 16/10 column (GE Healthcare) equilibrated in
buffer D. RhoG was eluted with buffer D containing an increasing concentration of NaCl. The
fractions containing RhoG were then loaded onto a GST-Sepharose affinity column
equilibrated in buffer C to remove residual amounts of GST-tagged protein. The flow-through
from the GST column was buffer exchanged into buffer C, concentrated, and stored at −80°C.
Mutations in Trio DH/PH and Rac1 were made using the Quikchange site directed mutagenesis
kit (Stratagene) following manufacturer's instructions. Sequences were verified using
automated sequencing. Mutants of Trio and Rac1 were purified as described above for wild-
type Trio and Rac1, respectively.
Guanine nucleotide exchange assays
Nucleotide exchange was measured using a fluorescence based assay, similar to published
protocols,28; 58 in which N-methylanthraniloyl (mant)-GTP was loaded onto the GTPase.
Spectroscopic analysis was carried out using a Perkin-Elmer LS 55 spectrometer at 20°C. The
exchange assay mixture containing 20 mM Tris pH 7.5, 50 mM NaCl, 10 mM MgCl2, 1 mM
DTT, 100 uM mant-GTP, and 2 uM GTPase was allowed to equilibrate with constant stirring.
Trio was then added at 50 or 400 nM for exchange assays with RhoG or Rac1, respectively,
and nucleotide exchange was measured by monitoring the decrease in intrinsic tryptophan
fluorescence (λex=295 nm, λem=335 nm) of the GTPase due to the binding of mant-GTP. The
data were fit to one phase exponential decay curves using the program GraphPad Prism™ in
order to determine the rate of nucleotide exchange.
Protein preparation for formation of Trio/Rac1 complex
Human Trio DH/PH (residues 1226 – 1536) was cloned in a pPROEX-HTa vector (Invitrogen)
using NcoI and XhoI cleavage sites, expressed as a fusion protein with an N-terminal His6-tag
in BL21 (DE3)s E. coli strain, and eluted from a Ni2+-Sepharose affinity column (GE
Healthcare) as described above. The His6-tag was removed by cleavage with TEV while
dialyzing (16 hrs) against a buffer containing 50 mM Tris, pH 8, 2 mM DTT, 2mM EDTA,
150 mM NaCl, and 5% glycerol. The removal of the His6-tag was confirmed using SDS-PAGE.
The protein was then stored at 4°C until it was used to form a complex with Rac1.
Rac177 was expressed from the pET15b vector (Novagen) in BL21 (DE3)s E .coli strain and
protein was purified according to published protocols.12 Minor variations include that the 45%
ammonium sulfate pellet was resuspended in 20 mM Tris, pH 8, 2 mM DTT, 1 mM MgCl2,
and 10 μM GDP and dialyzed extensively against buffer E (20 mM Tris pH 8, 10 mM NaCl,
2 mM DTT, 1 mM MgCl2, and 10 μM GDP) to remove the ammonium sulfate and increase
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the pH. The resuspended pellet was loaded onto a Q-Sepharose Fast Flow 26/10 column (GE
Healthcare) instead of a size-exclusion column. Rac177 was eluted from the column using
buffer E with increasing amounts NaCl. The fractions containing Rac177 were pooled together
and stored at 4°C before being used to form a complex with Trio.
Crystallization of the Trio/Rac177 complex
The Trio/Rac177 complex was formed in the presence of an excess of nucleotide-free Rac177
in 20 mM Tris, pH 8, 2 mM DTT, 4mM EDTA, 200 mM NaCl, and 5% glycerol. The complex
was purified on a 26/60 Sephacryl-200 size exclusion column equilibrated with 20 mM Tris,
pH 8, 2 mM DTT, 4 mM EDTA, 200 mM NaCl, and 5% glycerol. Fractions containing purified
complex were pooled together, dialyzed into a buffer containing 50 mM NaCl, 10 mM Tris, 2
mM EDTA, and 2 mM DTT, concentrated to ∼21 mg/ml, and stored at −80°C.
Trio/Rac177 crystals were obtained by vapor diffusion at 18 °C. Drops were formed by
combining equal volumes of protein complex and reservoir solution (100 mM sodium
cacodylate pH 5.5 – 6.5, 14 – 18% (w/v) PEG 8000 (FLUKA), and 300-500 mM calcium
acetate). Crystals typically appeared after 2 – 3 days and grew to final dimensions of 0.1 × 0.1
× 0.05 mm after several days. Crystals were cryoprotected by increasing the glycerol
concentration of the drop to 21% (v/v) in 3% increments. Cryoprotected crystals were then
suspended in a rayon loop (Hampton Research) and snap frozen in liquid nitrogen. The crystals
belong to the space group P21212 with unit cell parameters a = 97.492 Å, b = 108.558 Å, and
c = 53.416 Å.
Data collection and structure determination
A native data set was collected using a single frozen crystal at the SER-CAT beamline (ID-22,
Advanced Photon Source). Data were integrated and scaled using DENZO and
SCALEPACK59. Phases were calculated by molecular replacement using the Trio DH/
PH43 and Rac112 structures. The calculations were performed using both AMORE60 and
PHASER61 from the CCP4 suite of programs,62 which yielded identical solutions.
Model building and structure refinement
Electron density maps were calculated using CNS.63 The interactive graphics program O was
used for the majority of the model building,64 but the molecular graphics program COOT65
was also used to add water molecules. Most of the subsequent refinement was performed using
CNS;63 however, due the conformational mobility of the PH domain, CNS refinement was
unable to produce clear density for this region of the molecule. Thus, TLS refinement from the
CCP4 program Refmac547; 48 was used to improve the quality of the electron density maps.
Using Rac1, the DH domain, the PH domain, and the waters as TLS “groups” and employing
tight geometrical restraints (matrix diagonal weighing term = 0.06), a final model with Rwork
= 22.3% and Rfree = 24.9% was produced. In addition, the torsion angles for every non-glycine
residue are within the most favored or allowed regions of the Ramachandran diagram, as
determined by PROCHECK.66 Please refer to Table 1 for refinement statistics.
The simulated annealing omit map used to validate the interactions seen at the interface between
Rac1 and the PH domain of Trio was generated from the final coordinates after omitting
residues involved in this interface (residues 64 – 68, and 102 – 104 from Rac1 and residues
1405 – 1411, 1429 – 1431, and 1469 – 1473 from Trio).
All images of protein structures, with the exception of Figure 2(d), were generated using Pymol.
67 The images in Figure 2(d) displaying the theoretical anisotropic motion of the atoms68 were
generated using CCP4MG.69; 70 Pymol67 was also used to calculate buried surface areas.
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Protein Data Bank accession codes
The atomic coordinates and structure factors (code 2NZ8) have been deposited in the Protein
Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New
Brunswick, NJ.
Cell culture and transfection
To introduce point mutations (H1410A, Q1430A, and Y1472F) into EGFP-Trio FL wild-type
(human) (generously donated by Dr. Anne Debant, Centre de Recherche en Biochimie
Macromoléculaire, Montpellier, France), a section of Trio containing the N-terminal DH/PH
cassette (Trio DH/PH-long) was subcloned into the pMCSG7 vector.71 Mutations were
introduced using the Quikchange site directed mutagenesis kit (Stratagene) following
manufacturer's instructions and verified by automated sequencing. The DH/PH cassette of Trio
was then digested from Trio DH/PH-long and subcloned into EGFP-Trio FL.
PC-12 cells were cultured in DMEM containing 10% horse serum (HS), 5% fetal bovine serum
(FBS), and 1x penicillin/streptomycin (100 units/ml penicillin; 0.1 mg/ml streptomycin) at 37°
C in the presence of 5% CO2. For transfection, cells were seeded at a density of 500,000 cells
per well on glass coverslips coated with rat-tail collagen type I (BD biosciences) in 6-well
dishes. Cells were cultured for 18 hrs and then transfected with 1 μg of EGFP-C2 vector
(Clonetech), EGFP-RhoG wild-type (human) (generously donated by Dr. Keith Burridge,
UNC-Chapel Hill), or EGFP-Trio FL (wild-type and mutant forms) per well using
Lipofectamine plus (Invitrogen) according to the manufacturer's instructions. Cells were fixed
48 to 72 hours post transfection for 10 minutes with 3.7% (v/v) paraformaldehyde in PBS,
permeabilized with 0.3% Triton X-100, stained for actin with Alexa Fluor 546 phalloidan
(Invitrogen), washed, and mounted using Fluorsave Reagent (Calbiochem) according the
manufacturer's instructions.
Image collection and data processing for neurite outgrowth assays
Fixed cells were observed using an Olympus Fluoview 300 laser scanning confocal microscope
with a 60X PL APO oil immersion objective when scoring for neurite positive cells. Neurite
outgrowth activity was determined by positively scoring transfected cells displaying one or
more neurites greater than one cell body in length. Cells found in large clumps (> 10 cells)
were excluded from analysis. Displayed results represent the average of 3 independent
experiments in which at least 100 cells per condition were counted for each experiment. In
addition, the studies were blinded to conceal which slides contained cells that had been
transfected with wild-type and mutant versions of Trio.
Images were obtained using an Olympus Fluoview 1000 laser scanning confocal microscope
with 60× PL APO oil immersion objective in 20 – 30 micron XYZ stacks. Final images were
processed in ImageJ72 and represent a standard deviation projection of the compiled stacks.
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(a) Crystallized fragment of Trio is highlighted within the domain architecture of full-length
Trio. (b) Residues of Dbs (arrows) that mediate contacts between its N-terminal PH domain
and cognate GTPases are conserved in other Dbl-family GEFs, including Trio. The relative
position of these residues in context of the DH/PH cassette is indicated in Figure 3.
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Crystal structure of the DH/PH fragment of Trio bound to nucleotide-free Rac1.
(a) The N-terminal DH (yellow) and PH (blue) domains of Trio are bound to nucleotide-
depleted Rac1 (green with switch regions in red). Disordered regions are indicated with dotted
lines. (b) Atomic details of the interface between Rac1 and the PH domain of Trio. Hydrogen
bonds (2.6 – 4.0 Å) are indicated with dotted lines (c) A simulated annealing omit map (left)
contoured at 1.0σ and a 2Fo-Fc map (right) contoured at 1.2σ generated using the final
coordinates highlight the electron density at the interface between Rac1 and the PH domain.
(d) The anisotropic motion of each atom is displayed as a thermal ellipse (left). An identical
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image without the thermal ellipses is shown as a reference (right). The interface between Rac1
and the PH domain of Trio, also depicted in Figure 2(b) and 2(c), is highlighted by the box.
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Secondary structure of the DH/PH fragment of Trio.
The crystal structure of the Trio fragment bound to Rac1 was used to define α-helices and β-
strands according to nomenclature standardized for DH/PH cassettes.12 Secondary structure
assignments were made using the program DSSP,73 coupled with visual assessment. Residues
highlighted in red contribute to the interface between the PH domain of Trio and Rac1. Residues
in gray are disordered and were not modeled.
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The PH domains of Trio and Dbs interact similarly with their cognate GTPases.
DH/PH fragments of Trio (a) and Dbs (b) in complex with their cognate GTPases have been
superimposed upon equivalent, unbound fragments (gray) using the DH domains. (c and d)
Lower panels highlight conserved interactions found in both GEF/GTPase complexes that
require specific residues involving the PH domains. Color scheme is maintained from Figure
2.
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Mutations that disrupt the interface between the PH domain of Trio and Rac1 diminish
nucleotide exchange.
Residues within, or supported by, the PH domain of Trio that form the interface with Rac1
were mutated and the exchange activities of the mutants were measured on both Rac1 (a) and
RhoG (b). (c) Residues of Rac1 that interact directly with the PH domain of Trio were also
analyzed. Exchange assays (n=2) were carried out as described in Methods. Exchange rates
are reported as a percentage of the exchange rate of wild-type Trio (a and b) or as fold exchange
over the intrinsic exchange rate of the respective mutant of Rac1 (c). Proteins (5 μg) were
subjected to SDS-PAGE and stained with Coomassie Blue (insets) to verify purity and
concentration. (d) Circular dichroism spectroscopy confirmed the proper folding of Trio DH/
PH fragments.
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Mutations within, or supported by, the PH domain of Trio that reduce GTPase activation in
vitro also reduce the capacity of full-length Trio to induce neurite outgrowth in PC-12 cells.
(a) Neurite outgrowth in transfected PC-12 cells was assessed as described in Methods (*; p-
values < 0.05 in comparison to wild-type Trio using student's T-test). (b) Representative images
of transfected PC-12 cells show both GFP fluorescence (left) and filamentouse actin stained
with Alexa Fluor 546 phalloidin (right). All constructs were GFP-tagged at the N-terminus.
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Table 1
Data collection and refinement statistics.
Data collection
Wavelength (Å) 1.0712
Resolution (Å) 19.4 – 2.0
Total observations 213,443
Unique reflections 39,416
Completeness (%)1 99.6 (99.8)
I/σ,12 38.1 (3.5)
Rsym1,3 (%) 6.9 (52.4)
Refinement statistics







  Bond distances (Å) 0.009












Values for the highest resolution shell are given in parentheses.
2
I/σ is the mean signal to noise ratio, where I is the integrated intensity for a measured reflection and σ is the estimated error in the measurement.
3
Rsym = 100 × ∑|I – <I>|/ ∑I, where I is the integrated intensity for a measured reflection.
4
Rwork = ∑|Fo – Fc|/∑Fo, where Fo and Fc are the observed and calculated structure factor amplitudes, respectively
5
Rfree is calculated similarly to Rwork using test set reflections.
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